Rang	Name	Position
1	Dr. Christian Martin Itin Ph.D.	CEO & Director
2	Dr. Martin Pule M.D., MBBS	Founder, Senior VP & Chief Scientific Officer
3	Mr. Robert F. Dolski	Senior VP & CFO
4	Mr. Christopher Vann	Senior VP & COO
5	Mr. Patrick McIlvenny	Senior VP of Finance, Chief Accounting Officer & Principal Accounting Officer
6	Ms. Miranda Neville	Senior VP & Chief Technology Officer
7	Mr. Alex Driggs	Senior VP of Legal Affairs & General Counsel and Secretary
8	Mr. Alexander Swan	Senior VP & Chief Human Resources Officer
9	Dr. Christopher Williams Ph.D.	Senior VP & Chief Business Development Officer
10	Dr. Matthias Will M.D.	Senior VP & Chief Development Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Mak Capital One LLC	12,63%	63,21 Mio. USD
2	Blackstone Inc	7,70%	38,51 Mio. USD
3	Syncona Portfolio Ltd.	6,25%	31,29 Mio. USD
4	Armistice Capital, LLC	5,94%	29,70 Mio. USD
5	Polygon Management Ltd	3,57%	17,86 Mio. USD
6	Schroder Investment Management Group	2,94%	14,73 Mio. USD
7	Frazier Life Sciences Management, L.P.	1,67%	8,36 Mio. USD
8	BNP Paribas Investment Partners SA	1,26%	6,32 Mio. USD
9	LAURION CAPITAL MANAGEMENT LP	1,25%	6,24 Mio. USD
10	Renaissance Technologies Corp	0,86%	4,32 Mio. USD
11	Bank of America Corp	0,69%	3,47 Mio. USD
12	BlackRock Inc	0,56%	2,78 Mio. USD
13	UBS Group AG	0,49%	2,46 Mio. USD
14	Millennium Management LLC	0,46%	2,30 Mio. USD
15	Cetera Investment Advisers	0,42%	2,12 Mio. USD
16	Balyasny Asset Management LLC	0,37%	1,83 Mio. USD
17	Morgan Stanley - Brokerage Accounts	0,35%	1,77 Mio. USD
18	JPMorgan Chase & Co	0,35%	1,76 Mio. USD
19	Alphabet Inc	0,26%	1,31 Mio. USD
20	Citadel Advisors Llc	0,26%	1,31 Mio. USD